BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29190912)

  • 1. RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer.
    Fei W; Chen L; Chen J; Shi Q; Zhang L; Liu S; Li L; Zheng L; Hu X
    Oncotarget; 2017 Nov; 8(54):92254-92264. PubMed ID: 29190912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction of a fecal protein Luminex liquid chip detection system for early diagnosis of colorectal tumors].
    Li J; Yin L; Zhang M; Xia Y; Zuo L; Liu M; Hu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1874-1880. PubMed ID: 38081604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer.
    Xiong L; Zhu C; Lu Y; Chen M; Li M
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15671-15677. PubMed ID: 37658862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer.
    Li L; Zhang L; Tian Y; Zhang T; Duan G; Liu Y; Yin Y; Hua D; Qi X; Mao Y
    Front Oncol; 2019; 9():921. PubMed ID: 31649870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis.
    Hong J; Chen X; Chen L; Wang Y; Huang B; Fang H
    Cancer Manag Res; 2023; 15():563-572. PubMed ID: 37426393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
    Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
    Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free Fatty Acid is a Promising Biomarker in Triage Screening for Patients with Colorectal Cancer: A Case-Control Study.
    Zhu B; Zhang J; Zheng Q; Dong B; Wang M; Liu J; Cao Y
    Cancer Manag Res; 2021; 13():3749-3759. PubMed ID: 34007210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value of Serum Thrombospondin-2 Combined with CA19-9 in Early Diagnosis of Gastric Cancer.
    Li L; Dong J; Fu L; Xia X; Pan F; Ning Y
    J Oncol; 2021; 2021():2483964. PubMed ID: 34659407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of matrix metalloproteinases 2, 7 and 9 in urine for early detection of colorectal cancer.
    Peng L; Zhang X; Zhang ML; Jiang T; Zhang PJ
    World J Gastrointest Surg; 2023 May; 15(5):931-939. PubMed ID: 37342853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.
    Wang HF; Li LF; Guo SH; Zeng QY; Ning F; Liu WL; Zhang G
    Sci Rep; 2016 Sep; 6():33440. PubMed ID: 27678333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
    Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
    Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.
    Qiu B; Chu LY; Li XX; Peng YH; Xu YW; Xie JJ; Chen XY
    Onco Targets Ther; 2020; 13():12131-12139. PubMed ID: 33262611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patients.
    Brierley GV; Priebe IK; Purins L; Fung KY; Tabor B; Lockett T; Nice E; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Burgess A; Cosgrove LJ
    Cancer Biomark; 2013; 13(2):67-73. PubMed ID: 23838134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.